Results 291 to 300 of about 217,506 (303)

Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications

Biomaterials, 2020
Qiaobing Xu, Zheng-Yi Chen, Yamin Li
exaly  

CRISPR/Cas9 in Genome Editing and Beyond

Annual Review of Biochemistry, 2016
Lei S Qi, Haifeng Wang
exaly  

Inhibition of CRISPR-Cas9 with Bacteriophage Proteins

Cell, 2017
Michael Mcgregor, Judd Hultquist, Melanie Silvis   +2 more
exaly  

NHEJ and CRISPR–Cas9 improve gene therapy

Nature Reviews Molecular Cell Biology, 2016
Zlotorynski Eytan, Eytan Zlotorynski
exaly  

INHIBITORS OF CRISPR-CAS9

2018
BONDY-DENOMY JOSEPH, RAUCH BENJAMIN
openaire   +3 more sources

Naturally Occurring Off-Switches for CRISPR-Cas9

Cell, 2016
Nadia Amrani, Karen Maxwell, Alan Davidson   +2 more
exaly  

The Potential of CRISPR/Cas9 in Hematotherapy

Stem Cells and Development, 2019
openaire   +2 more sources

Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing

ACS Nano, 2017
Rubul Mout, Vincent Rotello, Tristan Tay   +2 more
exaly  

Engineered CRISPR-Cas9 nucleases

2016
J KEITH JOUNG, BENJAMIN KLEINSTIVER, VIKRAM PATTANAYAK   +2 more
openaire   +14 more sources

Allergan dives into CRISPR–Cas9

Nature Biotechnology, 2017
openaire   +2 more sources